## Core Concept
The question revolves around the management of a child exposed to H1N1 influenza, specifically focusing on the appropriate antiviral regimen for a child whose mother died from H1N1 and is now showing symptoms of upper respiratory infection (UI), likely indicating influenza-like illness.

## Why the Correct Answer is Right
The correct answer, **Oseltamivir**, is appropriate for several reasons:
- **Oseltamivir** is a neuraminidase inhibitor effective against influenza A and B viruses, including the H1N1 strain.
- For children, the dosing of oseltamivir is based on weight: 30 mg (for 15-22.9 kg) or 45 mg (for 23-33 kg) twice daily for 5 days.
- The child is 11 months old and likely in a high-risk category given the recent exposure and symptoms.

## Why Each Wrong Option is Incorrect
- **Option A (Ribavirin):** This is not typically used for influenza A or B. It's more commonly used for respiratory syncytial virus (RSV) infection and some cases of hepatitis C.
- **Option B (Zanamivir):** While zanamivir is another neuraminidase inhibitor like oseltamivir, it's usually administered via inhalation, which might not be practical or suitable for an 11-month-old child.
- **Option D (Amantadine):** This drug is used for influenza A but not for H1N1 due to widespread resistance. It's also not the first choice for a child.

## Clinical Pearl / High-Yield Fact
A key point to remember is that **oseltamivir** is specifically recommended for post-exposure prophylaxis and treatment of influenza, especially in high-risk groups like children under 2 years, pregnant women, and those with certain chronic health conditions. Early initiation of antiviral treatment is crucial for effectiveness.

## Correct Answer Line
**Correct Answer: C. Oseltamivir**.